A detailed history of Mariner, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Mariner, LLC holds 11,761 shares of CORT stock, worth $651,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,761
Previous 11,944 1.53%
Holding current value
$651,912
Previous $388,000 40.21%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$29.51 - $46.26 $5,400 - $8,465
-183 Reduced 1.53%
11,761 $544,000
Q2 2024

Aug 13, 2024

BUY
$22.21 - $34.48 $265,276 - $411,829
11,944 New
11,944 $388,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.94B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.